Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Biol Clin (Paris). 2003 Sep-Oct;61(5):533-40.

[Hormone determination in the management and monitoring of cycles of medically-assisted reproductive technology: value and difficulties of use].

[Article in French]

Author information

  • 1Service de biochimie et d'hormonologie, Hôpital Antoine Béclère, Clamart. joelle.taieb@abc.ap-hop-paris.fr

Abstract

In assisted reproductive technology (ART), serum levels of several key hormones are used to evaluate ovarian follicular reserve and to monitor gonadotropin-stimulated follicle growth. Currently, serum estradiol, FSH, LH and inhibin B levels are examined and combined at the beginning of the menstrual cycle to evaluate the functional status of the ovaries, providing information for appropriate ovarian stimulation treatment and prognosis for in vitro fertilization (IVF) outcome. In women undergoing in vitro fertilization and embryo transfer (IVF-ET), ovulation stimulation is monitored by serial measurements of estradiol, progesterone and LH to monitor follicular growth, evaluate the progression of stimulation, adjust daily gonadotropin therapy for each patient, and predict the optimal day for the induction of ovulation. We analyze the importance of each hormone and discuss the discrepancies frequently reported resulting from differences in methods.

PMID:
14671750
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Libbey Eurotext
    Loading ...
    Write to the Help Desk